NeuroVigil
Moffett Field
About NeuroVigil
NeuroVigil creates advanced non-invasive brain monitoring technology, including the iBrain device, to detect biomarkers associated with various neurological conditions. The company focuses on providing high-resolution EEG data for research purposes, enabling studies on conditions like ALS and autism without the stress of traditional hospital settings.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Funding stage: Early Stage Venture
- Last round: Series B (May 2015)
- Website: neurovigil.com
- Phone: 858-454-5134
Industries & Categories
Biotechnology, Clinical Trials, Health Care, Medical Device, Neuroscience
Social Profiles
Canonical: https://fsome.com/organization/neurovigil-2220978 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.